ArticleFrontiers in oncology2022

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a

Emanuela Palmerini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.